Risk of Dependence on Private-Label Products
First written in FY2019. 3 of 4 entries say "Restated". Latest entry: FY2024.
The whole theme swung hardest in 2024: 13 of 48 companies on the "Worse" side.
29 other companies' latest entry also says "Restated".
- FY2024RestatedAnnual report
「The proportion of private-label products in the Group's gross profit is high. Therefore, if sales of private-label products decline for any reason, the Group's operating performance may be affected.」
The proportion of private-label products in gross profit is high, and the risk that a decline in private-label product sales will affect performance remains. - FY2023RestatedAnnual report
「The proportion of private-label products in the Group's gross profit is high. Therefore, if sales of private-label products decline for any reason, the Group's operating performance may be affected.」
The proportion of private-label products in gross profit is high, and the risk that a decline in private-label product sales will affect performance remains. - FY2020RestatedAnnual report
「The proportion of private-label products in the Group's gross profit is high. Therefore, if sales of private-label products decline for any reason, the Group's operating performance may be affected.」
The proportion of private-label products in gross profit is high, and the risk that a decline in private-label product sales will affect performance remains. - FY2019First statedAnnual report
「Private-label products account for a high proportion of the Group's gross profit. Accordingly, if sales of private-label products decline for any reason in the future, this could affect the Group's performance.」
The company has disclosed as a separate risk its high dependence on private-label product sales for gross profit and the possibility that declining private-label product sales could affect performance.